Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Actuarial Approach01:20

Actuarial Approach

101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

197
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
197

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Temporal trends in mortality involving chronic lower respiratory disease and chronic kidney disease: evidence from CDC WONDER, 1999-2023.

BMC nephrology·2026
Same author

Secondary Vesical Calculi in a Young Male With Post-Gunshot Neurogenic Bladder and Prior Colostomy: A Case Report.

Clinical case reports·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Machine Learning for Revision Joint Arthroplasty: A Systematic Review of Distinct Challenges, Current Performance, and Clinical Readiness.

Arthroplasty today·2026
Same author

What Is the Relationship Between Clinician-reported and Patient-reported Outcomes in Orthopaedic Surgery?

Clinical orthopaedics and related research·2026

相关实验视频

Updated: Jul 28, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

307

预测软组织肉瘤患者的五年死亡率.

Teja Yeramosu1, Waleed Ahmad1, Azhar Bashir2

  • 1School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.

The bone & joint journal
|May 31, 2023
PubMed
概括

瘤大小,M阶段和组织学亚型是软组织肉瘤 (STS) 患者五年癌症相关死亡率的关键预测因素. 机器学习模型可以准确预测存活率,帮助肢体和干部STS的治疗决策.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

150

相关实验视频

Last Updated: Jul 28, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

307
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

150

科学领域:

  • 在瘤学瘤学.
  • 机器学习在医学中的应用
  • 生物统计学 生物统计学

背景情况:

  • 软组织肉瘤 (STS) 是一种罕见的恶性瘤,预后可变.
  • 确定预测癌症相关死亡率的因素对于患者管理至关重要.
  • 现有的预测模型可能无法完全捕捉到STS结果的复杂性.

研究的目的:

  • 确定与四肢和干部STS五年癌症相关死亡率相关的关键因素.
  • 开发和验证用于预测这种死亡率的机器学习 (ML) 算法.
  • 为改善风险分层和治疗规划提供工具.

主要方法:

  • 从SEER数据库 (2004-2017) 中分析人口统计,临床病理和治疗数据.
  • 多变量后勤回归用于识别显著的死亡预测因素.
  • 使用AUC,校准和决策曲线分析开发和比较各种ML模型 (例如随机森林).
  • 在机构数据集上对表现最好的模型进行外部验证.

主要成果:

  • 分析了13,646名STS患者;35.9%的患者经历了五年癌症相关死亡率.
  • 随机森林模型表现出卓越的性能.
  • 瘤大小是最重要的预测因素,其次是M阶段,组织学亚型,年龄和外科切除.
  • 通过外部验证,AUC达到0.752.

结论:

  • 确定了用于预测STS死亡率的临床重要变量.
  • 一个经过验证的ML模型为癌症相关死亡率提供了良好的准确性和可预测性.
  • 这些发现可以帮助骨科瘤学家对患者进行风险分层并优化治疗策略.